The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 23 January 2004, www.theannals.com, DOI 10.1345/aph.1D355.
 The Annals of Pharmacotherapy: Vol. 38, No. 3, pp. 490-493. DOI 10.1345/aph.1D355
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ooi, S.-T.
Right arrow Articles by Gardner, W. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ooi, S.-T.
Right arrow Articles by Gardner, W. G

DRUG INFORMATION ROUNDS

OBJETIVO: Repasar la literatura en cuanto al manejo de la bacteriuria asintomática (BAS) en pacientes con diabetes mellitus.

FUENTES DE INFORMACIÓN: Se realizo una búsqueda en MEDLINE (1967 a junio 2003) y un repaso bibliográfico de la literatura en idioma inglés usando los términos como diabetes mellitus, bacteriuria, e infección del tracto urinario.

SÍNTESIS DE INFORMACIÓN: BAS ocurre más común en mujeres diabéticas y está asociado con un riesgo creciente en infecciones sintomáticas de las vías urinarias entre pacientes con diabetes tipo 2. Infecciones del tracto urinario sintomático tienden a seguir un curso más complicado en los diabéticos. A pesar de estas observaciones independientes, la terapia antimicrobiana no ha demostrado ser eficaz en reducir la infección urinaria sintomática, el pielonefritis, o la hospitalización debido a infecciones de las vías urinarias.

CONCLUSIONES: La evidencia disponible no apoya el tratamiento antimicrobiano del BAS entre pacientes con diabetes mellitus.

www.theannals.com, DOI 10.1345/aph.1D355


This article has been cited by other articles:


Home page
 J EndocrinolHome page
A. Nareika, Y.-B. Im, B. A Game, E. H Slate, J. J Sanders, S. D London, M. F Lopes-Virella, and Y. Huang
High glucose enhances lipopolysaccharide-stimulated CD14 expression in U937 mononuclear cells by increasing nuclear factor {kappa}B and AP-1 activities
J. Endocrinol., January 1, 2008; 196(1): 45 - 55.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ooi, S.-T.
Right arrow Articles by Gardner, W. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ooi, S.-T.
Right arrow Articles by Gardner, W. G

homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.